Star Imaging and Path Lab Share Price
75.20-1.02 (-1.34%)
-42.60% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
APOLLOHOSP-ANSE
MAXHEALTH-ANSE
ASTERDM-ANSE
FORTIS-ANSE
NH-ANSE
MEDANTA-ANSE
LALPATHLAB-ANSE
KIMS-ANSE
AGARWALEYE-ANSE
VIJAYA-ANSE
STARIMAGIN-MNSE
Star Imaging and Path Lab Share Price
75.20-1.02 (-1.34%)
-42.60% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | 7% | 6% |
| - | - | 36% | 28% |
| - | - | - | -42% |
| 32% | 32% | 31% | 41% |
Peer Comparison
Symbol
APOLLOHOSP-A
MAXHEALTH-A
ASTERDM-A
FORTIS-A
NH-A
MEDANTA-A
LALPATHLAB-A
KIMS-A
AGARWALEYE-A
VIJAYA-A
STARIMAGIN-M
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 7,810 | ₹113202 Cr | 54.18 | 40.39 | 207.67 | ₹1942 Cr |
| 853 | ₹84036 Cr | 57.68 | 3.31 | 19.84 | ₹1442 Cr |
| 676 | ₹60058 Cr | 188.46 | 0.31 | 6.76 | ₹388 Cr |
| 749.4 | ₹57075 Cr | 54.47 | 3.53 | 20.1 | ₹1042 Cr |
| 1,681 | ₹34466 Cr | 42.23 | 10.14 | 65.36 | ₹806 Cr |
| 1,282.5 | ₹34447 Cr | 61.94 | 5.91 | 29.85 | ₹556 Cr |
| 1,930.8 | ₹32084 Cr | 59.21 | 10.11 | 42.51 | ₹505 Cr |
| 694.95 | ₹29768 Cr | 145.71 | 1.04 | 12.74 | ₹241 Cr |
| 468.7 | ₹14956 Cr | 100.8 | 1.43 | 13.88 | ₹133 Cr |
| 1,405.75 | ₹14522 Cr | 77.45 | 5.16 | 27.53 | ₹173 Cr |
| 76.9 | ₹132 Cr | 6.82 | 5.3 | 14.47 | ₹19 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| — | — | — | — |
| ₹14 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| ₹34 Cr | ₹30 Cr | ₹17 Cr | ₹17 Cr |
| ₹34 Cr | ₹30 Cr | ₹17 Cr | ₹17 Cr |
| ₹47 Cr | ₹31 Cr | ₹19 Cr | ₹18 Cr |
| ₹8 L | ₹5 L | ₹1 L | ₹99,000 |
| ₹14 Cr | ₹11 Cr | ₹11 Cr | ₹12 Cr |
| ₹1 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr |
| ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr |
| ₹82 L | ₹80 L | ₹81 L | ₹69 L |
| ₹17 Cr | ₹18 Cr | ₹16 Cr | ₹19 Cr |
| — | — | — | — |
| ₹9 Cr | ₹11 Cr | ₹12 Cr | ₹4 Cr |
| ₹6 Cr | ₹6 Cr | ₹95 L | ₹2 Cr |
| ₹13 Cr | ₹12 Cr | ₹12 Cr | ₹13 Cr |
| ₹6 Cr | ₹4 Cr | ₹88 L | ₹3 Cr |
| ₹34 Cr | ₹33 Cr | ₹26 Cr | ₹21 Cr |
| ₹98 Cr | ₹82 Cr | ₹61 Cr | ₹58 Cr |
| ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr |
| ₹33 Cr | ₹31 Cr | ₹27 Cr | ₹30 Cr |
| — | — | — | — |
| ₹68 Cr | ₹64 Cr | ₹51 Cr | ₹49 Cr |
| ₹48 Cr | ₹43 Cr | ₹37 Cr | ₹34 Cr |
| ₹21 Cr | ₹22 Cr | ₹13 Cr | ₹15 Cr |
| ₹0 | ₹0 | ₹6 Cr | ₹0 |
| ₹8 Cr | ₹5 Cr | ₹15 Cr | ₹12 Cr |
| ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹14 L |
| ₹31 Cr | ₹28 Cr | ₹35 Cr | ₹27 Cr |
| — | — | — | — |
| ₹24 L | ₹53 L | ₹63 L | ₹8 L |
| ₹51 Cr | ₹33 Cr | ₹18 Cr | ₹16 Cr |
| ₹5 Cr | ₹16 Cr | ₹2 Cr | ₹9 Cr |
| ₹37 L | ₹10 L | ₹33 L | ₹17 L |
| ₹11 Cr | ₹4 Cr | ₹5 Cr | ₹6 Cr |
| ₹67 Cr | ₹53 Cr | ₹26 Cr | ₹32 Cr |
| ₹33 Cr | ₹21 Cr | ₹24 L | ₹10 Cr |
| ₹98 Cr | ₹82 Cr | ₹61 Cr | ₹58 Cr |
| ₹35 | ₹209 | ₹126 | ₹122 |
| ₹35 | ₹23 | ₹14 | ₹14 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| ₹21 Cr | ₹16 Cr | ₹89 L | ₹9 Cr |
| ₹7 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr |
| -₹29 Cr | -₹35 L | -₹15 L | ₹3 Cr |
| -₹59 L | ₹22 Cr | ₹6 Cr | ₹17 Cr |
| -₹6 Cr | ₹18 Cr | ₹5 Cr | ₹14 Cr |
| -₹4 Cr | -₹7 Cr | -₹7 Cr | -₹4 Cr |
| -₹37 L | ₹2 Cr | -₹5 Cr | -₹7 Cr |
| -₹10 Cr | ₹13 Cr | -₹7 Cr | ₹3 Cr |
| ₹16 Cr | ₹2 Cr | ₹9 Cr | ₹6 Cr |
| ₹5 Cr | ₹16 Cr | ₹2 Cr | ₹9 Cr |
Fundamental Ratios
Consolidated
Standalone

No results found
Star Imaging and Path Lab Share Price
75.20-1.02 (-1.34%)
-42.60% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 0
Bearish signals: 6 out of 9 oscillators
RSI
41.34Sell
STOCH %K
28.81Neutral
MACD Level(12,26)
-2.16Sell
Ultimate Oscillator
43.65Sell
Aroon Oscillator
-68.00Sell
BOP
-1.00Sell
CCI
-22.29Neutral
Williams %R
-71.19Neutral
Momentum
-1.29Sell
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 0
Bearish signals: 9 out of 9 moving averages
EMA 9
75.89Sell
SMA 9
75.53Sell
EMA 21
77.51Sell
SMA 21
76.61Sell
EMA 50
81.12Sell
SMA 50
83.27Sell
EMA 200
90.92Sell
SMA 200
79.58Sell
WMA 20
75.95Sell
Pivot
Pivot
Classic
Resistance 5
85.47
Resistance 4
83.07
Resistance 3
80.67
Resistance 2
78.27
Resistance 1
77.25
Pivot
75.87
Support 1
74.85
Support 2
73.47
Support 3
71.07
Support 4
68.67
Support 5
66.27
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Star Imaging and Path Lab Share Price
75.20-1.02 (-1.34%)
-42.60% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Sep 2026 | Mar 2026 | Sep 2025 | Aug 2025 |
|---|---|---|---|
| 71.92% | 71.92% | 71.92% | 71.92% |
| 0.06% | 0.61% | 1.37% | 1.18% |
| 4.87% | 4.69% | 8.73% | 10.78% |
| 0.00% | 0.00% | 0.00% | 0.00% |
| 23.15% | 22.78% | 17.98% | 16.12% |
Bulk & block deals
Name
Amit Kumar Sangwan
Strategic Sixth Sense Capital Fund
Share India Securities Limited
Achintya Securities Pvt. Ltd.
Share India Securities Limited
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 25 Jun 2026 | Purchase | 90.48 L | ₹88.71 | 1.02 L | Bulk | 0.585534 | BSE |
| 01 Sep 2025 | Sell | 2.90 Cr | ₹142.19 | 2.04 L | Bulk | 1.171068 | BSE |
| 18 Aug 2025 | Purchase | 1.66 Cr | ₹141.90 | 1.17 L | Bulk | 0.671642 | BSE |
| 18 Aug 2025 | Purchase | 1.63 Cr | ₹141.64 | 1.15 L | Bulk | 0.660161 | BSE |
| 18 Aug 2025 | Sell | 63.85 L | ₹138.80 | 46 K | Bulk | 0.264064 | BSE |
Insider trading & SAST
Client name
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|
Star Imaging and Path Lab Share Price
75.20-1.02 (-1.34%)
-42.60% past 1 Year
Star Imaging and Path Lab is primarily engaged in operating pathology and diagnostic centers. It offers a comprehensive range of diagnostic imaging services and clinical laboratory tests, including both routine
Corporate Actions
Date
Type
Details
Company details
Star Imaging and Path Lab Share Price
75.20-1.02 (-1.34%)
-42.60% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Star Imaging and Path Lab Share Price
75.20-1.02 (-1.34%)
-42.60% past 1 Year
News
Star Imaging And Path Lab informs about investor presentation
Equity
STARIMAGIN
Star Imaging and Path Lab board to consider audited financial results
Equity
STARIMAGIN
Star Imaging executes lease agreement for setting up Diagnostic and Imaging Centre in New Delhi
Equity
STARIMAGIN
Star Imaging and Path Lab empanelled by BIS, IPGCL
Equity
STARIMAGIN
Star Imaging and Path Lab informs about disclosure
Equity
STARIMAGIN
Star Imaging and Path Lab empanelled by WDRA for providing medical treatment
Equity
STARIMAGIN

